Tumor necrosis factor-308 polymorphism with the risk and prognosis of non-Hodgkin lymphomas: a meta-analysis study [Corrigendum]
Gao S, Zhu G, Lin Y, et al. Onco Targets Ther. 2016;9: 1657–1670.On page 1657, the author affiliations were listed as:Sicheng Gao1,*Guoqing Zhu2,*Yan Lin1Xingliang Fan1Pingan Qian1Junfeng Zhu3Yongchun Yu11Central Laboratory, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shan...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2016-05-01
|
| Series: | OncoTargets and Therapy |
| Online Access: | https://www.dovepress.com/corrigendum-tumor-necrosis-factor-308-polymorphism-with-the-risk--peer-reviewed-article-OTT |